added to each chromatin aliquot. Antibodies used in this study: anti-H3K27ac (ab4729, Abcam), anti-H3K4me1 (ab8895, Abcam), anti-H3K4me2 (ab7766, Abcam), anti-H3K4me3 (ab8580, Abcam), anti-H3K27me3 (07-449, EMD Millipore), anti-H3K36me3 (ab9050, Abcam). Specificity of all antibodies was validated using Absurance H3 Histone Peptide Array Millipore) .
ChIP samples were incubated overnight at 4℃ on a rotisserie. Chromatin was then immunoprecipitated on a magnet and supernatant was discarded. Beads were washed 8 times with 1 mL of 500 mM LiCl ChIP-Seq Wash Buffer and once with 1 mL of TE. Chromatin was eluted from the beads twice with ChIP Elution buffer at 65℃ for 10 minutes with constant agitation. Combined eluates for each ChIP were subjected to crosslink reversal overnight at 65℃. Samples were then sequentially treated with RNAse A and proteinase K, purified with a PCR Purification Kit (Qiagen), and eluted in 50 uL of EB. ChIP samples were then quantified with picoGreen (ThermoFisher) and prepared for sequencing on Illumina instruments using the Thruplex 48S Library Prep kit (Rubicon Genomics) according to manufacturer's instructions. 
QUANTIFICATION AND STATISTICAL ANALYSIS Primary ChIP-Seq Data Analysis
Sequencing data was directly retrieved from Illumina's Basespace Cloud service using Basemount command line tools provided by Illumina. Multiple FASTQs for each ChIP were combined and assessed for quality using FASTQC (v0.11.2) (Andrews, 2010 ) and compared visually using MultiQC (v0.9) (Ewels et al., 2016) . Reads were then aligned to the human genome (hg19) using Bowtie2 (v2.2.5) (Langmead and Salzberg, 2012) keeping only uniquely mapped reads. Fragment sizes of each library were estimated using PhantomPeakQualTools (v.1.14) (Landt et al., 2012) . Histone modification enriched regions were identified and annotated using HOMER (v4.8.3) (Heinz et al., 2010) . Reproducibly enriched regions were determined by creating a union of all enriched regions for a respective histone modification from all replicates of a single Carnegie stage and filtering for regions identified in at least two biological replicates using BEDtools (v2.25.0) (Quinlan and Hall, 2010) . We then generated pvalue based signal tracks relative to appropriate input controls based on estimated library fragment size using MACS2 (2.1.1.20160309) (Feng et al., 2012) . All signal and enriched region files were converted for display in the UCSC Genome Browser using the Kent Source Tools (v329) (Kent et al., 2002) . Correlations of ChIP-Seq signals and Principal Component Analysis across samples and marks were calculated in non-overlapping 10kb windows using deepTools2 (v2.5.0.1) (Ramírez et al., 2014) .
Roadmap Epigenome and cultured CNCC Data Retrieval
Aligned and consolidated primary ChIP-Seq reads in tagAlign format were retrieved from Roadmap Epigenome for eleven epigenomic signals: H2A.Z, H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me3, H3K27ac, H3K27me3, H3K36me3, H3K79me2, and H4K20me1.
(http://egg2.wustl.edu/roadmap/data/byFileType/alignments/consolidated/). To ensure the most compatible signals with our data, p-value signals were generated by MACS2 from these data based on library fragment sizes reported by Roadmap Epigenome as above. DNase p-value signals were retrieved directly from Roadmap Epigenome (http://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/pval/) and converted from bigWig to bedGraph for use with ChromImpute (Ernst and Kellis, 2015) using Kent Source Tools (Kent et al., 2002) . Chromatin state segmentations for 127 epigenomes and associated 15-, 18-, and 25-state model files were retrieved from Roadmap Epigenome (http://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/).
Raw reads for all human CNCC ChIP-Seq from Prescott et al 2015 were retrieved from GEO accession GSE70751 and processed using procedures as above.
Chromatin Imputation
Bedgraph files for all p-value signals from primary ChIP-Seq data were converted to 25 bp resolution and processed for model training and generation of imputed signals for all samples using ChromImpute (v1.0.1) as previously described (Ernst and Kellis, 2015) . Resulting imputed signal tracks were converted to bigWig format for display in UCSC genome browser and converted to combined signal format at 200 bp resolution for use with ChromHMM (v1.12) (Ernst and Kellis, 2012 ) using deepTools2 (Ramírez et al., 2014) .
Chromatin State Segmentation
Signal files for individual chromosomes for each craniofacial epigenome were binarized and segmentation was performed using previously published joint 15-, 18-, and 25-state chromatin models using ChromHMM as previously described (Roadmap Epigenomics et al., 2015) .
Following segmentation, annotation of states and generation of genome browser files was performed based on annotations provided by Roadmap Epigenome. Individual models of 15, 18 and 25 chromatin states were also learned for each craniofacial epigenome using default settings in ChromHMM. Pearson Correlations and Principal Component Analyses were performed on total H3K27ac signals extracted observed in all imputed p-value signal tracks for craniofacial and Roadmap Epigenome samples from the union of all enhancer state segmentations (EnhA1, EnhA2, EnhAF, EnhW1, EnhW2, and EnhAc) using deepTools2 (Ramírez et al., 2014) . All plots were made in R (v3.3.3) (R Core Team, 2017) using tabular data generated by deepTools2.
Functional Enrichments in Craniofacial Epigenomes
Craniofacial enhancer state segmentations (EnhA1, EnhA2, EnhAF, EnhW1, EnhW2, and EnhAc) were interrogated for tissue activity in the developing mouse embryo from the Vista Enhancer Browser (Visel et al., 2007) . Significance of overlap of enhancers identified in human craniofacial tissue and shown to be active in mouse craniofacial tissue relative to all other tissue annotations was determined using Fisher's exact test. To identify totally novel craniofacial enhancers, enhancer state segmentations for all craniofacial segmentations were interrogated for single base overlap with the same states from all Roadmap Epigenomes using BEDtools (Quinlan and Hall, 2010) . These novel craniofacial enhancer segmentations were assessed for gene ontology and functional enrichments based on assigned target genes using GREAT (v3.0.0) (McLean et al., 2010) . Genes identified as transcriptional regulators by GREAT were assessed for enrichment of anatomical expression using default parameters in GeneORGANizer (Gokhman et al., 2017) . Sequence from novel craniofacial enhancer segmentations was extracted from hg19 using fastaFromBed within BEDTools (Quinlan and Hall, 2010) . The resulting sequences were assessed for transcription factor motif enrichment using HOMER (Heinz et al., 2010) . Enhancer state segmentations from craniofacial epigenomes and all Roadmap epigenomes were interrogated for significance of overlap with GWAS tag SNPs associated with orofacial clefting and craniofacial morphology (Beaty et al., 2011; Birnbaum et al., 2009; Grant et al., 2009; Ludwig et al., 2012; Mangold et al., 2010; Shaffer et al., 2016; Shi et al., 2012) obtained from the GWAS Catalog (retrieved 2017-02-20) (Welter et al., 2014 ) using Fisher's exact test within BEDTools (Quinlan and Hall, 2010) . Adjusted p-value thresholds for 154 comparisons were determined using the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) .
Identification of Enhancer Clusters
Enhancers have been shown to cluster spatially over long distances and within topological domains (Ing-Simmons et al., 2015) , thus to identify clusters of craniofacial enhancers we first generated overlapping 200kb windows (median contact domain size from high resolution Hi-C (Rao et al., 2014) ) with a 50kb step size using BEDtools (Quinlan and Hall, 2010) . Next, we intersected these windows with all enhancer chromatin state segmentations from craniofacial tissues. We then calculated the fraction of each window annotated as an enhancer state. We tested for enrichment of enhancers in each window using permutation testing by randomly shuffling the craniofacial enhancer segments across the genome 1000 times using BEDtools (Quinlan and Hall, 2010) and determining the fraction of each window annotated as an enhancer. Permutation p-values were corrected using the Benjamini-Hochberg method (Benjamini and Hochberg, 1995) for 60739 200kb windows and additionally filtered for a minimum fraction of enhancer states of 0.15 to ensure strong enhancer activation. Overlapping windows passing these criteria were merged into a single contiguous region. Final enriched regions were assessed for overlap with gene annotations and validated craniofacial enhancers using BEDtools (Quinlan and Hall, 2010) . We also identified super-enhancer regions using H3K27ac ChIP-Seq reads at all craniofacial enhancer segments with default parameters in ROSE (Whyte et al. 2013 ).
DATA AND SOFTWARE AVAILABILITY
All data can be visualized in the UCSC Genome Browser using publically available track hub functionality. Hub files and interesting browser examples can be found on our website: http://cotney.research.uchc.edu/data/ ChIP-Seq signals, peak calls, chromatin state segmentations are available at GEO accession GSE97752.
All generic scripts used in processing ChIP-Seq and generating chromatin states are available on github: https://github.com/cotneylab/ChIP-Seq Primary ChIP-Seq Data c.
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Overlaps with CF Enhancers random trials random trials observed observed Counts Counts Figure S4 . Overlap with CNCC enhancers and All Enhancers Tested for Craniofacial Activity a. Distribution of overlaps of CNCC active enhancer regions with 10,000 trials of random enhancer sets equal in number, length, and chromosomal distribution to the top 10% of craniofacial enhancer segments (n=7500). Red vertical line indicates observed number of overlaps between CNCC enhancers and craniofacial enhancers. b. Distribution of overlaps of human biased CNCC enhancer regions with 10,000 trials of random enhancer sets equal in number, length, and chromosomal distribution to the top 10% of craniofacial enhancer segments (n=7500). Red vertical line indicates observed number of overlaps between human biased CNCC enhancers and craniofacial enhancers. c. All enhancers identified and tested by this study from the Vista Enhancer Browser. Enhancers with hs prefix indicated the human genomic sequence was tested while those with the mm prefix indicate that the orthologous sequence from mouse identified by this study was tested. Related to Figure 5 . 1 Mb hg19 128,500,000 129,000,000 129,500,000 130,000,000 130,500,000 131,000,000 the GWAS Catalog in enhancer segmentations assessed using GREGOR (Schmidt et al., 2015) . Orange circles indicate craniofacial enhancer annotations identified by a 25 State chromatin model from this study while grey circles indicate those previously published by Roadmap Epigenome (Roadmap Epigenomics et al., 2015) . No significant enrichment was detected for craniofacial segmentations,but was observed for multiple immune cell types. b. Same analysis as in a using GWAS tag SNPs reported for orofacial clefting by Leslie et al 2017. c. Same analysis as in a using GWAS tag SNPs reported for 24 regions by Ludwig et al 2017. Related to Figure 7 . Figure S10 Orofacial Clefting Locus 1p36.13 PAX7 Approximately 2Mb window surrounding PAX7 (A). The region selected for targeted sequencing (Leslie et al. 2015) . The lead SNP rs742071 and the associated SNP by sequencing, rs1339062, are shown. The PAX7 promoter region was also investigated in Ludwig et al. (2017) where rs4920524 was identified as contributing the largest posterior probability risk. Bivalent states (purple) are present at the PAX7 promoter and the promoter of IGSF21. A craniofacial superenhancer overlaps the PAX7 bivalent region (B) and SNPs including rs1339062, rs742071 and rs4920524 are present within a portion of the superenhancer region that has not been identified as a superenhancer in any tissues or cell types in the dbSuper database (Khan and Zhang, 2016) . Other large craniofacial superenhancers carrying craniofacial-specific enhancers are within 1Mb of PAX7. The region near IFFO2 (C) is shown as an example. Related to Figure 7 . Figure S12 Orofacial Clefting Locus 1p22.1 ARHGAP29 Approximately 2Mb region surrounding rs560426 (A). The region was selected for targeted sequencing (Leslie et al. 2015) . The region also contains rs35298667, identified as a likely significant contributor to nsCL/P (Ludwig et al., 2017) and multiple SNPs identified in GWAS for non-syndromic orofacial clefting (Yu et al. 2017 and Leslie et al. 2017 reported loci) are present within craniofacial superenhancer within the region of targeted resequencing (B). Additional craniofacial superenhancers including craniofacial-specific superenhancer regions neighboring the region of targeted resequencing (C). Related to Figure 7 . (Leslie et al., 2015) or GWAS (Yu et al., 2017; Leslie et al., 2017) are found near enhancers active in craniofacial tissue. (B) Craniofacial-specific enhancers and craniofacialspecific superenhancers located adjacent to the region of targeted sequencing (C). Related to Figure 7 . Figure S15 Orofacial Clefting Locus 15q13.3 GREM1 Approximately 2Mb region containing the intergenic region between GREM1 and FMN1, found to have a strong association with nsCL/P and to be predominant in a rare form of clefting with lip and soft palate cleft but intact hard palate (Ludwig et al. 2016 ) (A). SNPs identified in the intergenic region and in the promoter and intronic region of FMN1 are shown in panel B. The SNP rs17816375, found to have the strongest eQTL effect by Ludwig et al. is near craniofacial-specific enhancers in the intron of FMN1. Additionally, FMN1 introns contain many enhancer states with patterns that suggest differences in enhancer activity between embryonic and fetal craniofacial development (C). Related to Figure 7 .
GWAS loci selected for targeted sequencing in Leslie et al. 2015 A B B (Matsui and Klingensmith, 2014) . SNPs associated with nonsyndromic oral clefts reside near or in enhancer states active in early craniofacial development (B,C). Related to Figure 7 . Cranofacial-specific enhancers GWAS loci selected for targeted sequencing in Leslie et al. 2015 Cranofacial-specific enhancers B C Ludwig et al. 2017 SNPs Ludwig et al. 2017 SNPs rs13041247
Figure S17 Orofacial Clefting Locus 20q12 MAFB Approximately 2Mb region around MAFB (A). SNPs associated with non-syndromic oral clefts reside in or near enhancer states active in early craniofacial development (B). A region <1Mb away from MAFB contains several craniofacial-specific enhancers and patterns of enhancer state that may suggest differences in early vs. late craniofacial development (C). Related to Figure 7 .
